HUM:NYE-Humana Inc (USD)

COMMON STOCK | Healthcare Plans | NYE

Last Closing Price

USD 425.49

Change

-4.09 (-0.95)%

Market Cap

USD 54.73B

Volume

0.95M

Avg Analyst Target

USD 482.80 (+13.47%)

Avg User Target

USD
Average Analyst Rating

Verdict

Fundamental Analysis

Verdict

About

Humana Inc., together with its subsidiaries, operates as a health and well-being company in the United States. It operates through Retail, Group and Specialty, and Healthcare Services segments. The company offers medical and supplemental benefit plans to individuals. It also has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits. In addition, the company provides commercial fully-insured medical and specialty health insurance benefits comprising dental, vision, and other supplemental health benefits; and administrative services only products to individuals and employer groups, as well as military services, such as TRICARE T2017 East Region contract. Further, it offers pharmacy solutions, provider services, predictive modeling and informatics services, and clinical care services, such as home health and other services to its health plan members, as well as to third parties. As of December 31, 2020, the company had approximately 17 million members in medical benefit plans, as well as approximately 5 million members in specialty products. Humana Inc. was incorporated in 1964 and is headquartered in Louisville, Kentucky.

Technical Indicators

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2021-08-03 )

Largest Industry Peers for Healthcare Plans

Symbol Name Price(Change) Market Cap Price / Earning Ratio EV/EBITDA
UNH UnitedHealth Group Incorporate..

+6.33 (+1.52%)

USD389.01B 27.23 17.37
CVS CVS Health Corporation

+1.59 (+1.93%)

USD108.43B 14.67 10.59
ANTM Anthem, Inc

+5.00 (+1.28%)

USD93.63B 22.72 N/A
CI Cigna Corporation

+4.61 (+2.01%)

USD78.62B 9.86 N/A
CNC Centene Corporation

-0.98 (-1.39%)

USD40.99B 57.63 14.52
MOH Molina Healthcare, Inc

+3.20 (+1.17%)

USD15.94B 25.54 9.55
GTS Triple-S Management Corporatio..

+0.08 (+0.33%)

USD0.58B 4.86 N/A

ETFs Containing HUM

Symbol Name Weight Mer Price(Change) Market Cap
DEUS Xtrackers Russell US Mult.. 0.00 % 0.17 %

+0.44 (+0.99%)

USD0.20B
IHF iShares U.S. Healthcare P.. 0.00 % 0.42 %

+2.54 (+0.94%)

USD1.44B
XHS SPDR Series Trust - SPDR .. 0.00 % 0.35 %

+1.11 (+0.99%)

USD0.21B
VSDA VictoryShares Dividend Ac.. 0.00 % 0.35 %

+0.22 (+0.49%)

USD0.34B
HIG:CA Brompton Global Healthcar.. 0.00 % 0.97 %

+0.06 (+0.56%)

USD0.05B
UTRN Vesper U.S. Large Cap Sho.. 0.00 % 0.75 %

+0.22 (+0.62%)

USD0.07B

Market Performance

  Market Performance vs.
Industry/Classification (Healthcare Plans)
Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 3.71% 13% F 37% F
Dividend Return 0.34% 20% F 11% F
Total Return 4.05% 13% F 33% F
Trailing 12 Months  
Capital Gain 8.77% 13% F 29% F
Dividend Return 0.68% 20% F 9% F
Total Return 9.45% 13% F 26% F
Trailing 5 Years  
Capital Gain 144.77% 50% F 87% B+
Dividend Return 5.91% 40% F 16% F
Total Return 150.69% 50% F 86% B
Average Annual (5 Year Horizon)  
Capital Gain 21.53% 50% F 84% B
Dividend Return 0.75% 50% F 21% F
Total Return 22.28% 50% F 83% B
Risk Return Profile  
Volatility (Standard Deviation) 20.78% 63% D 53% F
Risk Adjusted Return 107.21% 63% D 93% A
Market Capitalization 54.73B 50% F 95% A
Letter Grade Percentage Letter Grade Percentage Letter Grade Percentage
A+ 97%-100% A 93%-96% A- 90%-92%
B+ 87%-89% B 83%-86% B- 80%-82%
C+ 77%-79% C 73%-76% C- 70%-72%
D+ 67%-69% D 63%-66% D- 60%-62%
F 0%-59%

Key Financial Ratios

  Ratio vs. Industry/Classification
(Healthcare Plans)
Ratio vs. Market
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
Market Value  
Price / Earning Ratio 22.53 63% D 36% F
Price/Book Ratio 3.69 38% F 28% F
Price / Cash Flow Ratio 9.70 25% F 45% F
EV/EBITDA N/A N/A N/A N/A N/A
Management Effectiveness  
Return on Equity 16.97% 63% D 76% C
Return on Invested Capital 19.04% 88% B+ 91% A-
Return on Assets 6.43% 88% B+ 84% B
Debt to Equity Ratio 44.14% 88% B+ 66% D
Technical Ratios  
Short Ratio 1.56 100% A+ 59% F
Short Percent 0.92% 88% B+ 79% C+
Beta 0.89 38% F 65% D
Letter Grade Percentage Letter Grade Percentage Letter Grade Percentage
A+ 97%-100% A 93%-96% A- 90%-92%
B+ 97%-89% B 83%-86% B- 80%-82%
C+ 77%-79% C 73%-76% C- 70%-72%
D+ 67%-69% D 63%-66% D- 60%-62%
F 0%-59%

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

No discussions yet

User / Independent Analyst Ratings

User Name Target Rating Target Horizon (Months) Target Price User Analysis Date Comment

Fundamental Analysis Breakdown

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior capital utilization

The company management has delivered better return on invested capital in the most recent 4 quarters than its peers, placing it in the top quartile.

Superior return on assets

The company management has delivered better return on assets in the most recent 4 quarters than its peers, placing it in the top quartile.

Low debt

The company is less leveraged than its peers ,, and is among the top quartile, which makes it more flexible. However, do check the news and look at its sector. Sometimes this is low because the company is not growing and has no growth potential.

Positive cash flow

The company had positive total cash flow in the most recent four quarters.

Superior Dividend Growth

This stock has shown top quartile dividend growth in the previous 5 years compared to its sector

High Gross Profit to Asset Ratio

This stock is in the top quartile compared to its peers on Gross Profit to Asset Ratio. This is a popular measure among value investors for showing superior returns in the long run.

What to not like:
Low market capitalization

This is among the smaller entities in its sectors with below median market capitalization. That may make it less stable in the long run unless it has a unique technology or market which can help it grow or get acquired in future.

Below median total returns

The company has under performed its peers on annual average total returns in the past 5 years.

Below median dividend returns

The company’s average income yield over the past 5 years has been low compared to its peers. However, it is not a problem if you are not looking for income.

Overpriced compared to book value

The stock is trading high compared to its peers median on a price to book value basis.

Overpriced on cashflow basis

The stock is trading high compared to its peers on a price to cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.

Low Revenue Growth

This stock has shown below median revenue growth in the previous 5 years compared to its sector